isosorbide dinitrate has been researched along with Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, M; Pan, L; Payne, J | 1 |
2 other study(ies) available for isosorbide dinitrate and Kidney Failure
| Article | Year |
|---|---|
Question: does isosorbide dinitrate/hydralazine therapy benefit systolic heart failure patients with renal insufficiency?
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Drug Combinations; Evidence-Based Medicine; Heart Failure, Systolic; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Randomized Controlled Trials as Topic; Renal Insufficiency; Treatment Outcome | 2011 |
Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Cardiotonic Agents; Cohort Studies; Contraindications; Female; Hospitalization; Humans; Hydralazine; Hyperkalemia; Isosorbide Dinitrate; Male; Medicare; Middle Aged; Multivariate Analysis; Patient Discharge; Peer Review, Health Care; Professional Review Organizations; Renal Insufficiency; Retrospective Studies; Stroke Volume; United States; United States Agency for Healthcare Research and Quality; Vasodilator Agents | 1997 |